375.40
6.80 (1.84%)
| Penutupan Terdahulu | 368.60 |
| Buka | 368.60 |
| Jumlah Dagangan | 234,207 |
| Purata Dagangan (3B) | 311,782 |
| Modal Pasaran | 11,066,699,776 |
| Harga / Pendapatan (P/E TTM) | 49.27 |
| Harga / Pendapatan (P/E Ke hadapan) | 49.51 |
| Harga / Jualan (P/S) | 27.06 |
| Harga / Buku (P/B) | 8.66 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 3 Aug 2026 |
| Margin Keuntungan | 37.17% |
| Margin Operasi (TTM) | 41.03% |
| EPS Cair (TTM) | 4.18 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 94.90% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 3,734.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.98% |
| Nisbah Semasa (MRQ) | 9.65 |
| Aliran Tunai Operasi (OCF TTM) | 138.50 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 76.74 M |
| Pulangan Atas Aset (ROA TTM) | 8.66% |
| Pulangan Atas Ekuiti (ROE TTM) | 13.90% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Krystal Biotech, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -3.0 |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 4.0 |
| Purata | -0.13 |
|
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 11.88% |
| % Dimiliki oleh Institusi | 104.04% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| THOMAS JOHN CHARLES | - | 359.93 | -1,000 | -359,930 |
| Jumlah Keseluruhan Kuantiti Bersih | -1,000 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -359,930 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 359.93 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| THOMAS JOHN CHARLES | Pegawai | 25 Jun 2026 | Jual automatik (-) | 1,000 | 359.93 | 359,930 |
| THOMAS JOHN CHARLES | Pegawai | 25 Jun 2026 | Pelaksanaan pilihan | 1,000 | - | - |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |